×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVO – novo nordisk a/s (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
09:32 pm
nvo
Novo Nordisk Obesity Drug Data Sparks Questions On Valuation And Momentum [Yahoo! Finance]
Neutral
Report
Novo Nordisk Obesity Drug Data Sparks Questions On Valuation And Momentum [Yahoo! Finance]
3/18
02:36 pm
nvo
Analysis-TrumpRx lists many medicines at prices higher than paid in UK [Yahoo! Finance]
Low
Report
Analysis-TrumpRx lists many medicines at prices higher than paid in UK [Yahoo! Finance]
3/18
02:07 pm
nvo
Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says [CNBC]
Low
Report
Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says [CNBC]
3/18
02:00 pm
nvo
Novo Nordisk A/S (NVO) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $175.00 price target on the stock.
Low
Report
Novo Nordisk A/S (NVO) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $175.00 price target on the stock.
3/18
09:04 am
nvo
Is Novo Nordisk (NYSE:NVO) Starting To Look Interesting After A 52% One Year Slide? [Yahoo! Finance]
Low
Report
Is Novo Nordisk (NYSE:NVO) Starting To Look Interesting After A 52% One Year Slide? [Yahoo! Finance]
3/18
08:58 am
nvo
The Best Healthcare Stocks to Buy With $50 Right Now [Yahoo! Finance]
Low
Report
The Best Healthcare Stocks to Buy With $50 Right Now [Yahoo! Finance]
3/17
08:42 pm
nvo
India's cheap weight-loss drugs could reshape global obesity fight [Yahoo! Finance]
Low
Report
India's cheap weight-loss drugs could reshape global obesity fight [Yahoo! Finance]
3/17
07:24 pm
nvo
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move [Yahoo! Finance]
Low
Report
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/17
07:11 am
nvo
Form 6-K NOVO NORDISK A S For: Mar 16
Low
Report
Form 6-K NOVO NORDISK A S For: Mar 16
3/9
07:53 am
nvo
Form 6-K NOVO NORDISK A S For: Mar 09
Low
Report
Form 6-K NOVO NORDISK A S For: Mar 09
3/2
11:48 am
nvo
Form 6-K NOVO NORDISK A S For: Mar 02
Low
Report
Form 6-K NOVO NORDISK A S For: Mar 02
3/2
07:57 am
nvo
Form 6-K NOVO NORDISK A S For: Mar 02
Low
Report
Form 6-K NOVO NORDISK A S For: Mar 02
2/23
08:19 am
nvo
Form 6-K NOVO NORDISK A S For: Feb 23
Low
Report
Form 6-K NOVO NORDISK A S For: Feb 23
2/23
06:28 am
nvo
Form 6-K NOVO NORDISK A S For: Feb 23
Low
Report
Form 6-K NOVO NORDISK A S For: Feb 23
2/20
07:46 am
nvo
Form 6-K NOVO NORDISK A S For: Feb 20
Low
Report
Form 6-K NOVO NORDISK A S For: Feb 20
2/17
06:11 am
nvo
Form 6-K NOVO NORDISK A S For: Feb 16
Low
Report
Form 6-K NOVO NORDISK A S For: Feb 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
Form 6-K NOVO NORDISK A S For: Mar 16
6.0%
3/16 Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. 4.7%
2/5 Q4/2019 12/31/2019 EPS 3.700 ZacksConsensus 0.550 ActVsEst 3.150 - Beat 4.6%
6/8 Novo's oral semaglutide successful in two late-stage T2D studies [Seeking Alpha] 3.8%
11/8 Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha] 3.2%
3/27 Form 6-K NOVO NORDISK A S For: Mar 26 3.2%
8/12 Q2/2019 6/30/2019 EPS 4.030 ZacksConsensus 0.610 ActVsEst 3.420 - Beat 3.0%
9/17 With a backup to the backup, insulin makers say they're primed for Brexit [Reuters (UK)] 3.0%
11/1 Form 6-K NOVO NORDISK A S For: Nov 01 2.7%
8/8 Europe stocks climb in early action, led by pharmas [MarketWatch] 2.4%
3/16 Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. 4.7%
2/5 Q4/2019 12/31/2019 EPS 3.700 ZacksConsensus 0.550 ActVsEst 3.150 - Beat 4.6%
6/8 Novo's oral semaglutide successful in two late-stage T2D studies [Seeking Alpha] 3.8%
11/8 Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha] 3.2%
3/27 Form 6-K NOVO NORDISK A S For: Mar 26 3.2%
8/12 Q2/2019 6/30/2019 EPS 4.030 ZacksConsensus 0.610 ActVsEst 3.420 - Beat 3.0%
9/17 With a backup to the backup, insulin makers say they're primed for Brexit [Reuters (UK)] 3.0%
11/1 Form 6-K NOVO NORDISK A S For: Nov 01 2.7%
8/8 Europe stocks climb in early action, led by pharmas [MarketWatch] 2.4%
TOP News Decliners
9/9
Form 6-K NOVO NORDISK A S For: Sep 09
-3.6%
11/20 Form 6-K NOVO NORDISK A S For: Nov 20 -2.8%
12/18 Form 6-K NOVO NORDISK A S For: Dec 16 -2.5%
3/9 Form 6-K NOVO NORDISK A S For: Mar 09 -2.4%
4/7 Team Novo Nordisk and Beyond Type 1 Announce New Partnership -2.4%
1/3 Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News] -2.2%
4/28 Form 6-K NOVO NORDISK A S For: Apr 27 -2.1%
9/10 Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -2.1%
3/23 Form 6-K NOVO NORDISK A S For: Mar 23 -1.8%
10/1 Form 6-K NOVO NORDISK A S For: Sep 30 -1.6%
11/20 Form 6-K NOVO NORDISK A S For: Nov 20 -2.8%
12/18 Form 6-K NOVO NORDISK A S For: Dec 16 -2.5%
3/9 Form 6-K NOVO NORDISK A S For: Mar 09 -2.4%
4/7 Team Novo Nordisk and Beyond Type 1 Announce New Partnership -2.4%
1/3 Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News] -2.2%
4/28 Form 6-K NOVO NORDISK A S For: Apr 27 -2.1%
9/10 Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -2.1%
3/23 Form 6-K NOVO NORDISK A S For: Mar 23 -1.8%
10/1 Form 6-K NOVO NORDISK A S For: Sep 30 -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: